Home > About Us

Overview
Layn is a world leader with more than 15 years of dedication to the identification, development and production of active principles derived from plants that are traditionally recognized as having therapeutic properties with application in the food & beverage, nutrition, health and personal care industries. Layn is proud of its achievements.

Layn will continue its commitment to research and invest in the development of innovative and efficacious products.



1st Generation 1995                       2nd Generation 2002                                                       3rd Generation 2010
 
History
1995
--Started with production of Ginkgo Biloba Leaf Extract and Grape Seed Extract
2000--The new Layn started with 6 GMP extraction lines for dietary supplement ingredients
2002--Compliance to ISO9001 : 2000 achieved
2003--Established Layn's Natural Ingredients Research and Development Center
2003--Established Guilin Layn Pharmaceutical Inc. and received GMP pharmaceutical status in 2004
2005--Increased production capacity adding 8 additional GMP extraction lines
2007--on Shenzhen Stock Exchange under stock symbol: 002166, resulting in sufficient working capital for the  continued investment in world class manufacturing and technologies
2008--Government Accredited Natural Product Research Center staffed with a strong PhD team
2010--Inaugurated new factory and Life Science Center in Lin'gui county with 16 state-of-the-art, fully computer controlled cGMP extraction lines for a total capacity of 15,000MT raw material annually
2011-- Layn's Luo Han Guo (Monk Fruit) and Stevia got FDA GRAS affirmation
2011-- LAYN receives FDA GRAS Affirmation,Monk Fruit Natural Sweetener (Go-Luo®
2011-- LAYN receives FDA GRAS Affirmation,Stevia Natural Sweetener (Azevia®)
2011-- LAYN USA established as wholly owned U.S.subsidiary of Guilin LAYN Natural lngredients Corp.
2012-- LAYN launches Go-Luo®Monk Fruit Sweetener with national table top branda
2013-- Canada Approves Monk Fruit Extract in table top sweeteners,citing LAYN' s clinical dossier GRN# 359(FAD)
2016-- LAYN Shanghai R&D Center established
2016-- LAYN EUROPE Srl established